KommentarOpen Access
Small-molecule hypoxia therapy in mitochondrial disease
Cell · 2025
DOI: 10.1016/j.cell.2025.02.019 ↗Kurz gefasst
Kommentar in der Zeitschrift Cell, 2025. Verfasst von Marni J Falk. Beteiligte Einrichtung: Mitochondrial Medicine Frontier Program, Division of Human Genetics, Department of Pediatrics, Children's Hospital of Philadelphia and University of …. Hauptthemen laut MEDLINE: Mitochondrial Diseases, Hypoxia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Mitochondrial DiseasesHypoxiaAnimalsMiceHumansLeigh DiseaseDisease Models, AnimalOxyhemoglobins
Substanzen
Oxyhemoglobins
Autor:innen und Institutionen
- Mitochondrial Medicine Frontier Program, Division of Human Genetics, Department of Pediatrics, Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA.…
Förderung
- NIGMS NIH HHS
Zitieren
APA
Falk, M. J. (2025). Small-molecule hypoxia therapy in mitochondrial disease. Cell. https://doi.org/10.1016/j.cell.2025.02.019
Vancouver
Falk MJ. Small-molecule hypoxia therapy in mitochondrial disease. Cell. 2025. doi:10.1016/j.cell.2025.02.019
BibTeX
@article{Falk2025,
author = {Falk, Marni J},
title = {Small-molecule hypoxia therapy in mitochondrial disease},
journal = {Cell},
year = {2025},
doi = {10.1016/j.cell.2025.02.019}
}
EUVIMED